|
humans |
94 |
|
male |
66 |
|
children |
63 |
|
adult |
58 |
|
child |
58 |
|
female |
57 |
|
adolescent |
54 |
|
covid-19 |
52 |
|
child, preschool |
49 |
|
chinese |
48 |
|
middle aged |
46 |
|
hong kong - epidemiology |
41 |
|
hong kong |
35 |
|
infant |
32 |
|
vaccine |
28 |
|
sars |
22 |
|
cells, cultured |
21 |
|
genetic predisposition to disease |
21 |
|
animals |
20 |
|
infant, newborn |
20 |
|
asian continental ancestry group - genetics |
19 |
|
adolescents |
18 |
|
chemicals and cas registry numbers |
18 |
|
coronavac |
18 |
|
disease outbreaks - statistics & numerical data |
18 |
|
influenza a virus, h1n1 subtype - immunology |
18 |
|
epidemiology |
17 |
|
genome-wide association study |
17 |
|
genotype |
17 |
|
sle |
17 |
|
influenza, human - epidemiology - immunology - virology |
16 |
|
systemic lupus erythematosus |
16 |
|
aged |
15 |
|
prevalence |
15 |
|
seroepidemiologic studies |
15 |
|
single nucleotide polymorphism |
15 |
|
allergy |
14 |
|
asian |
14 |
|
association |
14 |
|
cytokines |
14 |
|
immunoglobulin |
14 |
|
polymorphism, genetic |
14 |
|
reverse transcriptase polymerase chain reaction |
14 |
|
sars-cov-2 |
14 |
|
acute disease |
13 |
|
antibodies, viral - blood |
13 |
|
bone marrow transplantation |
13 |
|
case-control studies |
13 |
|
cluster analysis |
13 |
|
immunity |
13 |
|
immunity, innate |
13 |
|
lupus erythematosus, systemic - genetics |
13 |
|
lymphocyte subsets |
13 |
|
phylogeny |
13 |
|
risk assessment |
13 |
|
viral load |
13 |
|
young adult |
13 |
|
animal tissue |
12 |
|
anorectal malformation |
12 |
|
asparaginase |
12 |
|
bnt162b2 |
12 |
|
chromosome aberration |
12 |
|
cohort studies |
12 |
|
convalescence |
12 |
|
cross-sectional studies |
12 |
|
ephrin-a2 - genetics |
12 |
|
hospitalization |
12 |
|
hospitalization - statistics & numerical data |
12 |
|
population surveillance |
12 |
|
sars-cov-2 rbd igg |
12 |
|
signal transduction |
12 |
|
t cell response |
12 |
|
uhrf1bp1 |
12 |
|
up-regulation |
12 |
|
wnt signaling pathway |
12 |
|
antigens, cd3 - genetics |
11 |
|
antimicrobial resistance |
11 |
|
autoantibodies - blood |
11 |
|
cd247 |
11 |
|
china - epidemiology |
11 |
|
feces - virology |
11 |
|
gwas |
11 |
|
incidence |
11 |
|
lupus erythematosus, systemic - enzymology - genetics |
11 |
|
lupus erythematosus, systemic - genetics - immunology |
11 |
|
phenotype |
11 |
|
prospective studies |
11 |
|
quality of life |
11 |
|
seasons |
11 |
|
severe acute respiratory syndrome |
11 |
|
severity of illness index |
11 |
|
stool |
11 |
|
t-lymphocytes, cytotoxic - immunology |
11 |
|
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
|
apoptosis |
10 |
|
asia |
10 |
|
autoimmunity |
10 |
|
birds |
10 |
|
china |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
cytokines - metabolism |
10 |
|
dead-box rna helicases - genetics - immunology - metabolism |
10 |
|
dendritic cells |
10 |
|
epithelial cells - immunology - metabolism |
10 |
|
gene expression regulation |
10 |
|
human leukocyte antigens |
10 |
|
hypersensitivity |
10 |
|
immunodeficiency |
10 |
|
infection |
10 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - immunology - metabolism - virology |
10 |
|
influenza, human - mortality |
10 |
|
interferon regulatory factor-3 - metabolism |
10 |
|
intracellular signaling peptides and proteins - genetics |
10 |
|
janus kinases - immunology |
10 |
|
macrophages - immunology |
10 |
|
macrophages - immunology - metabolism |
10 |
|
medical sciences |
10 |
|
molecular sequence data |
10 |
|
mutation |
10 |
|
nf-kappa b - metabolism |
10 |
|
omicron |
10 |
|
p38 mitogen-activated protein kinases - metabolism |
10 |
|
pandemics |
10 |
|
paracrine communication - immunology |
10 |
|
patient admission - statistics and numerical data |
10 |
|
polymorphism, single nucleotide |
10 |
|
pulmonary alveoli - immunology - metabolism |
10 |
|
receptor, interferon alpha-beta - immunology |
10 |
|
risk factors |
10 |
|
rna, small interfering - genetics |
10 |
|
rna, viral - metabolism |
10 |
|
t-lymphocytes |
10 |
|
toll-like receptor 3 - metabolism |
10 |
|
γδ-t cells |
10 |
|
age-stratified |
9 |
|
amino acid sequence |
9 |
|
congenital heart disease |
9 |
|
cross protection |
9 |
|
cross reactions |
9 |
|
immunoglobulin g - blood |
9 |
|
immunotherapy |
9 |
|
influenza, human - immunology - virology |
9 |
|
linkage disequilibrium |
9 |
|
markov chains |
9 |
|
meningitis |
9 |
|
mice |
9 |
|
molecular epidemiology |
9 |
|
monte carlo method |
9 |
|
multivariate analysis |
9 |
|
neutralization tests |
9 |
|
pediatric |
9 |
|
reproducibility of results |
9 |
|
severe acute respiratory syndrome - blood - epidemiology |
9 |
|
travel history |
9 |
|
alleles |
8 |
|
anaphylaxis |
8 |
|
anti-bacterial agents - pharmacology |
8 |
|
asthma |
8 |
|
bacteria |
8 |
|
child day care centers |
8 |
|
coronavirus - classification - genetics - isolation & purification |
8 |
|
coronavirus infections - epidemiology - physiopathology - virology |
8 |
|
dna mutational analysis |
8 |
|
drug |
8 |
|
fatal outcome |
8 |
|
gastroenteritis |
8 |
|
haplotypes |
8 |
|
hematopoietic stem cell transplantation |
8 |
|
infants |
8 |
|
infection control |
8 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
|
influenza, human - epidemiology - virology |
8 |
|
lupus |
8 |
|
lupus nephritis |
8 |
|
model |
8 |
|
nasopharynx - microbiology |
8 |
|
neonates |
8 |
|
pandemic |
8 |
|
post-covid-19 condition |
8 |
|
prediction |
8 |
|
prognosis |
8 |
|
respiratory system - virology |
8 |
|
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
|
retrospective studies |
8 |
|
seizures, febrile - epidemiology |
8 |
|
serial |
8 |
|
symptom burden |
8 |
|
urine |
8 |
|
urine - virology |
8 |
|
viral load - physiology |
8 |
|
virus cultivation |
8 |
|
virus shedding |
8 |
|
wiskott-aldrich syndrome |
8 |
|
antibodies, antinuclear - blood |
7 |
|
antigens, cd11b - genetics |
7 |
|
antiviral agents - administration and dosage - therapeutic use |
7 |
|
asian continental ancestry group - ethnology - genetics |
7 |
|
autoantibodies |
7 |
|
b-lymphocytes - immunology |
7 |
|
base sequence |
7 |
|
bocavirus - classification - genetics - isolation & purification |
7 |
|
bone marrow transplantation - adverse effects |
7 |
|
carrier proteins - genetics |
7 |
|
carrier state - microbiology |
7 |
|
common cold - virology |
7 |
|
coronavirus - immunology |
7 |
|
coronavirus infections - virology |
7 |
|
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
|
cytotoxicity |
7 |
|
diagnosis, differential |
7 |
|
disease susceptibility |
7 |
|
dna, complementary - genetics |
7 |
|
drug resistance |
7 |
|
drug resistance, bacterial |
7 |
|
epidemiology, molecular |
7 |
|
epistasis |
7 |
|
ets1 |
7 |
|
evolution, molecular |
7 |
|
fetal blood |
7 |
|
gastroenteritis - epidemiology - physiopathology - virology |
7 |
|
gene frequency |
7 |
|
genome, viral |
7 |
|
graft survival |
7 |
|
haplotype |
7 |
|
heterozygote |
7 |
|
il-17 |
7 |
|
immunogenicity |
7 |
|
immunological profiles |
7 |
|
immunophenotyping |
7 |
|
inborn errors of immunity |
7 |
|
influenza a virus, h1n1 subtype - genetics |
7 |
|
influenza, human - drug therapy - epidemiology - virology |
7 |
|
lupus erythematosus |
7 |
|
lupus erythematosus, systemic - ethnology - genetics |
7 |
|
lupus erythematosus, systemic - ethnology - immunology |
7 |
|
lymphocyte activation |
7 |
|
multigene family |
7 |
|
myelosuppression |
7 |
|
nephritis - ethnology - genetics |
7 |
|
oseltamivir - administration and dosage - therapeutic use |
7 |
|
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
|
polymerase chain reaction - methods |
7 |
|
protein-serine-threonine kinases - genetics |
7 |
|
recombination, genetic |
7 |
|
reference values |
7 |
|
respiratory tract infections - epidemiology - virology |
7 |
|
respiratory tract infections - virology |
7 |
|
rhinovirus - classification - genetics |
7 |
|
saliva |
7 |
|
sars-coronavirus seroprevalence |
7 |
|
sequence analysis, dna |
7 |
|
streptococcus pneumoniae |
7 |
|
systemic |
7 |
|
transplantation, homologous |
7 |
|
treatment outcome |
7 |
|
22q11.2 deletion syndrome (22q11.2ds) |
6 |
|
acyclovir - therapeutic use |
6 |
|
agammaglobulinemia |
6 |
|
age distribution |
6 |
|
age factors |
6 |
|
aged, 80 and over |
6 |
|
algorithms |
6 |
|
allergology and immunology |
6 |
|
antibiotic prophylaxis |
6 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
6 |
|
apoptosis - immunology |
6 |
|
asian continental ancestry group |
6 |
|
blood |
6 |
|
bone marrow aspiration |
6 |
|
carrier proteins - blood - genetics |
6 |
|
caveolins |
6 |
|
cell composition |
6 |
|
cell lineage-specific |
6 |
|
cfu-f |
6 |
|
challenge |
6 |
|
clinical phenotype |
6 |
|
confidence intervals |
6 |
|
conotruncal anomaly |
6 |
|
conservation |
6 |
|
coronavirus disease 2019 |
6 |
|
cytokines - biosynthesis - genetics |
6 |
|
diarrhea - microbiology |
6 |
|
disease progression |
6 |
|
disease transmission, infectious - statistics & numerical data |
6 |
|
dna methylation |
6 |
|
dysmorphism |
6 |
|
endemic diseases - statistics & numerical data |
6 |
|
extracellular vesicle |
6 |
|
family health |
6 |
|
fecal |
6 |
|
fever - diagnosis |
6 |
|
founder mutation |
6 |
|
gastroenteritis - epidemiology - virology |
6 |
|
gastrointestinal diseases - microbiology |
6 |
|
gene expression |
6 |
|
genetic testing |
6 |
|
gram-positive bacteria - isolation & purification |
6 |
|
gram-positive bacterial infections - microbiology |
6 |
|
h7n9 |
6 |
|
head and neck neoplasms |
6 |
|
hemagglutinins, viral - immunology |
6 |
|
heptavalent pneumococcal conjugate vaccine |
6 |
|
human rhinovirus c |
6 |
|
il-10 |
6 |
|
immune dysregulation |
6 |
|
immunocompromised host |
6 |
|
in situ hybridization, fluorescence |
6 |
|
influenza a virus - isolation & purification |
6 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
6 |
|
influenza a virus, h1n1 subtype - physiology |
6 |
|
influenza a virus, h5n1 subtype - physiology |
6 |
|
influenza a virus, h9n2 subtype - physiology |
6 |
|
influenza virus |
6 |
|
influenza, human - complications - diagnosis - epidemiology |
6 |
|
influenzavirus a - genetics - immunology - pathogenicity |
6 |
|
intradermal |
6 |
|
killer cells, natural - immunology - virology |
6 |
|
killer cells, natural - virology |
6 |
|
leukemia |
6 |
|
mass vaccination |
6 |
|
mesenchymal stromal cell |
6 |
|
metapneumovirus - isolation & purification |
6 |
|
methylationepic |
6 |
|
microbial sensitivity tests |
6 |
|
nerve tissue proteins - genetics |
6 |
|
neuromuscular diseases |
6 |
|
novel mutation |
6 |
|
orthomyxoviridae - immunology - pathogenicity |
6 |
|
paediatric-onset |
6 |
|
paramyxoviridae infections - diagnosis - epidemiology - virology |
6 |
|
picornaviridae infections - epidemiology - virology |
6 |
|
pneumococcal infections - microbiology |
6 |
|
pneumococcal vaccines |
6 |
|
polymerase chain reaction |
6 |
|
polymorphism, single nucleotide - genetics |
6 |
|
prematurity |
6 |
|
prevention |
6 |
|
probability |
6 |
|
promoter regions, genetic |
6 |
|
radiotherapy |
6 |
|
receptors, antigen, t-cell, gamma-delta - immunology |
6 |
|
regulation |
6 |
|
respiratory syncytial virus infections - diagnosis - epidemiology - virology |
6 |
|
respiratory syncytial viruses - isolation & purification |
6 |
|
respiratory tract infections - diagnosis - epidemiology - virology |
6 |
|
rhinovirus - classification - genetics - isolation and purification |
6 |
|
rna, messenger - analysis |
6 |
|
rna, viral - genetics |
6 |
|
sars virus - immunology - isolation & purification |
6 |
|
serotyping |
6 |
|
severe combined immunodeficiency |
6 |
|
sex distribution |
6 |
|
stat4 transcription factor - genetics |
6 |
|
streptococcus pneumoniae - drug effects - immunology |
6 |
|
streptococcus pneumoniae - immunology |
6 |
|
survival rate |
6 |
|
susceptibility |
6 |
|
t cell epitope |
6 |
|
t-lymphocytes - immunology - metabolism |
6 |
|
th1 cells - immunology |
6 |
|
tissue donors |
6 |
|
translocation, genetic |
6 |
|
tumor |
6 |
|
tumor microenvironment |
6 |
|
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
|
vaccines, conjugate |
6 |
|
virion - immunology |
6 |
|
virus internalization |
6 |
|
22q11.2 deletion |
5 |
|
age of onset |
5 |
|
alps-like disease |
5 |
|
ampk |
5 |
|
antigen presentation |
5 |
|
antigens, cd40 - immunology |
5 |
|
antiviral |
5 |
|
antiviral agents - pharmacology |
5 |
|
antiviral agents - therapeutic use |
5 |
|
arthritis, experimental - etiology - genetics - immunology - pathology |
5 |
|
autoimmune diseases |
5 |
|
autoimmune diseases - etiology - genetics - immunology |
5 |
|
avian influenza virus (aiv) |
5 |
|
b lymphocytes |
5 |
|
b-cell activating factor |
5 |
|
b-cell activation factor receptor |
5 |
|
b-lymphocytes - cytology - immunology |
5 |
|
b-lymphocytes - immunology - metabolism |
5 |
|
b-lymphocytes - immunology - pathology |
5 |
|
bacteremia - complications - epidemiology - etiology |
5 |
|
bacteria - isolation & purification |
5 |
|
beta-thalassemia - blood - immunology - therapy |
5 |
|
blood platelets - microbiology |
5 |
|
body height |
5 |
|
bronchiectasis |
5 |
|
case report |
5 |
|
cd8-positive t-lymphocytes - cytology - immunology |
5 |
|
cell division |
5 |
|
cell lineage - immunology |
5 |
|
cell proliferation |
5 |
|
child welfare |
5 |
|
child, hospitalized |
5 |
|
childhood lymphoma |
5 |
|
chromosomes, human, pair 1 - genetics |
5 |
|
chromosomes, human, pair 9 - genetics |
5 |
|
cmv |
5 |
|
coculture techniques |
5 |
|
cofactors |
5 |
|
collagen - immunology |
5 |
|
cord blood stem cell |
5 |
|
coronavirus |
5 |
|
counseling |
5 |
|
crohn disease |
5 |
|
cystic fibrosis |
5 |
|
cytokine |
5 |
|
cytomegalovirus - drug effects - genetics - isolation & purification |
5 |
|
cytoskeletal proteins - genetics |
5 |
|
cytotoxicity, immunologic |
5 |
|
dendritic cells - immunology |
5 |
|
dendritic cells - immunology - microbiology - virology |
5 |
|
deoxyribonucleases, type ii site-specific |
5 |
|
diphosphonates - pharmacology |
5 |
|
direction infection |
5 |
|
disease transmission, vertical - prevention & control |
5 |
|
dna, viral - blood - drug effects |
5 |
|
down-regulation |
5 |
|
encephalities |
5 |
|
enzyme-linked immunosorbent assay |
5 |
|
epilepsy - genetics |
5 |
|
exome |
5 |
|
fetal hemoglobin |
5 |
|
fetal hemoglobin - biosynthesis |
5 |
|
fetal tissue transplantation |
5 |
|
fever - etiology - therapy |
5 |
|
gamma ifn |
5 |
|
gene sequence |
5 |
|
genetic defect |
5 |
|
genome sequencing |
5 |
|
glucose metabolism |
5 |
|
glycosylation |
5 |
|
graft vs host disease |
5 |
|
hemagglutinin |
5 |
|
herpesviridae infections - blood - drug therapy - etiology |
5 |
|
herpesvirus 6, human - drug effects - genetics - isolation & purification |
5 |
|
herpesvirus 7, human - drug effects - genetics - isolation & purification |
5 |
|
heterozygosity |
5 |
|
histocompatibility testing |
5 |
|
hiv infections - diagnosis - transmission |
5 |
|
hospital |
5 |
|
human mesenchymal stem cells |
5 |
|
human t cell |
5 |
|
humanized mice |
5 |
|
immune memory |
5 |
|
immunoevasion |
5 |
|
influenza, human - immunology |
5 |
|
inhibition |
5 |
|
insulin-like growth factor i - pharmacology |
5 |
|
interleukin 10 receptor |
5 |
|
intradermal influenza vaccination |
5 |
|
isoantigens - immunology |
5 |
|
lactate |
5 |
|
leukocytes, mononuclear - virology |
5 |
|
longitudinal studies |
5 |
|
lupus erythematosus, systemic - blood - genetics |
5 |
|
mass screening - organization & administration |
5 |
|
membrane proteins - biosynthesis - genetics - immunology |
5 |
|
methotrexate |
5 |
|
mice, inbred c57bl |
5 |
|
mice, inbred dba |
5 |
|
molecular genetics |
5 |
|
motivation |
5 |
|
mutation - genetics |
5 |
|
mutation, missense |
5 |
|
nasopharynx - virology |
5 |
|
natural killer (nk) cell |
5 |
|
orthomyxoviridae infections - drug therapy - immunology - pathology |
5 |
|
paediatrics |
5 |
|
parainfluenza virus 4, human - classification - genetics - isolation & purification |
5 |
|
parents |
5 |
|
pcr |
5 |
|
pd-1/programmed death-ligand 1 |
5 |
|
pediatrics |
5 |
|
penicillium marneffei |
5 |
|
pericardial effusion |
5 |
|
pilot projects |
5 |
|
platelet transfusion - adverse effects |
5 |
|
pneumococcal infections - immunology |
5 |
|
policy |
5 |
|
precursor cell lymphoblastic leukemia-lymphoma - diagnosis - drug therapy - genetics |
5 |
|
prenatal diagnosis - methods |
5 |
|
primary immunodeficiencies |
5 |
|
primary prevention - organization & administration |
5 |
|
promoter regions, genetic - genetics |
5 |
|
pulmonary fibrosis |
5 |
|
rasgrp1 |
5 |
|
receptors, tumor necrosis factor - biosynthesis - genetics |
5 |
|
rna, messenger - genetics - metabolism |
5 |
|
rubulavirus infections - epidemiology - virology |
5 |
|
sex chromosome aberrations - diagnosis - genetics |
5 |
|
smoking cessation |
5 |
|
survival analysis |
5 |
|
t-cell antigen receptor specificity |
5 |
|
t-cell receptor signaling |
5 |
|
t-lymphocyte subsets - drug effects - immunology |
5 |
|
t-lymphocytes, regulatory - cytology - immunology |
5 |
|
t-lymphocytes, regulatory - immunology - metabolism |
5 |
|
t2dm |
5 |
|
thalassemia - complications |
5 |
|
time factors |
5 |
|
tobacco smoke pollution - prevention & control |
5 |
|
toll-like receptor 5 - antagonists and inhibitors - metabolism |
5 |
|
trafficking defects |
5 |
|
transplantation |
5 |
|
tumor necrosis factor-alpha - genetics - immunology |
5 |
|
tumor surveillance |
5 |
|
type i interferon |
5 |
|
vaccination |
5 |
|
x chromosome |
5 |
|
young infants |
5 |
|
β-thalassemia major |
5 |
|
γδ t cells |
5 |
|
adolescent girls |
4 |
|
allergy centre |
4 |
|
allergy services |
4 |
|
alpha-thalassemia - blood - complications - therapy |
4 |
|
anti-bacterial agents - therapeutic use |
4 |
|
antigens, cd27 - analysis |
4 |
|
antigens, cd45 - analysis |
4 |
|
aplastic anaemia |
4 |
|
ascites - etiology |
4 |
|
asia pacific |
4 |
|
asia, southeastern - epidemiology |
4 |
|
atp7b |
4 |
|
autoimmune diseases - epidemiology - ethnology |
4 |
|
b cells |
4 |
|
bacterial infections - epidemiology - ethnology |
4 |
|
bcg vaccine |
4 |
|
beta-thalassemia - genetics |
4 |
|
beta-thalassemia - physiopathology |
4 |
|
biological markers |
4 |
|
blood smear |
4 |
|
bone marrow examination |
4 |
|
bone marrow examination - methods |
4 |
|
bone marrow transplantation - pathology |
4 |
|
breast feeding - statistics & numerical data |
4 |
|
carcinoma, hepatocellular - blood - complications - genetics |
4 |
|
carrier state |
4 |
|
carrier state - epidemiology - microbiology |
4 |
|
cd8-positive t-lymphocytes - immunology - pathology - secretion |
4 |
|
cell function |
4 |
|
cell isolation |
4 |
|
cell migration |
4 |
|
central venous catheter |
4 |
|
chemotherapy |
4 |
|
child development |
4 |
|
child health services - utilization |
4 |
|
childhood |
4 |
|
chimera |
4 |
|
chronic kidney disease |
4 |
|
clinical article |
4 |
|
codon |
4 |
|
codon - genetics |
4 |
|
communication |
4 |
|
complement c4 - metabolism |
4 |
|
complication |
4 |
|
complications |
4 |
|
cord blood cell |
4 |
|
cord blood transplantation |
4 |
|
ctl |
4 |
|
cyanuric acid |
4 |
|
cyclin-dependent kinase inhibitor p21 - biosynthesis - genetics |
4 |
|
cytogenetics |
4 |
|
cytomegalovirus infections - blood - diagnosis - epidemiology |
4 |
|
day care centers |
4 |
|
development |
4 |
|
diamond-blackfan syndrome |
4 |
|
dna fingerprinting |
4 |
|
dna, viral - genetics - isolation & purification |
4 |
|
dna-binding proteins |
4 |
|
dress |
4 |
|
drug reaction with eosinophilia and systemic symptoms |
4 |
|
drug-induced hypersensitivity syndrome |
4 |
|
educational status |
4 |
|
family-centred paediatric nursing |
4 |
|
fetal blood - cytology - enzymology |
4 |
|
filipino (citizen) |
4 |
|
flow cytometry |
4 |
|
genetic heterogeneity |
4 |
|
globins - genetics |
4 |
|
graft vs host disease - immunology - pathology - prevention and control |
4 |
|
granulocytes |
4 |
|
h1n1 influenza virus |
4 |
|
haemophilus influenzae - drug effects |
4 |
|
hb bart's disease |
4 |
|
health resources |
4 |
|
hematopoietic stem cell transplantation - adverse effects - methods |
4 |
|
hemoglobin f |
4 |
|
hemoglobinopathies - blood - complications - therapy |
4 |
|
hemoglobins, abnormal |
4 |
|
hepatitis |
4 |
|
hepatitis b antibodies - blood |
4 |
|
hepatitis b surface antigens - analysis |
4 |
|
hepatitis b surface antigens - blood - metabolism |
4 |
|
hepatitis b, chronic - metabolism - physiopathology |
4 |
|
hepatolenticular degeneration - genetics |
4 |
|
histocompatibility - immunology |
4 |
|
hla mismatched |
4 |
|
hla-dr antigens |
4 |
|
homozygosity mapping |
4 |
|
hong kong chinese |
4 |
|
hospitalization - statistics and numerical data |
4 |
|
human |
4 |
|
human papillomavirus |
4 |
|
igf-1 |
4 |
|
il-2 |
4 |
|
immature dc |
4 |
|
immune thrombocytopenia |
4 |
|
immunity - immunology |
4 |
|
immunoglobulins |
4 |
|
immunology |
4 |
|
infant, newborn, diseases - epidemiology - prevention & control |
4 |
|
inflammation - immunology - metabolism |
4 |
|
influenza |
4 |
|
influenza a virus - immunology |
4 |
|
influenza a virus, h1n1 subtype - immunology - metabolism |
4 |
|
influenza a virus, h1n1 subtype - isolation and purification |
4 |
|
influenza a virus, h3n2 subtype - isolation and purification |
4 |
|
influenza a virus, h9n2 subtype - immunology - metabolism |
4 |
|
influenza b virus - isolation and purification |
4 |
|
influenza, human - epidemiology |
4 |
|
influenza, human - epidemiology - pathology - virology |
4 |
|
innate immunity |
4 |
|
interferon |
4 |
|
interferon regulatory factors - genetics |
4 |
|
interferon-gamma - immunology |
4 |
|
interleukin 10 |
4 |
|
interleukin-12 - biosynthesis - metabolism |
4 |
|
intussusception |
4 |
|
isolation |
4 |
|
karyotyping |
4 |
|
klebsiella infections - complications - drug therapy - epidemiology |
4 |
|
klebsiella pneumoniae - drug effects |
4 |
|
kw075 - genetic mapping |
4 |
|
kw078 – genome scan |
4 |
|
kw083 - genotype-phenotype correlations |
4 |
|
kw086 – identification of disease genes |
4 |
|
kw087 - immune system |
4 |
|
leukocytes - virology |
4 |
|
leukocytes, mononuclear |
4 |
|
leukocytes, mononuclear - cytology |
4 |
|
leukoencephalopathy |
4 |
|
linitis plastica - complications - diagnosis |
4 |
|
liver cirrhosis - genetics |
4 |
|
liver neoplasms - blood - complications - genetics |
4 |
|
lupus erythematosus, systemic - epidemiology - genetics |
4 |
|
lymphocyte activation - immunology |
4 |
|
lymphocyte depletion |
4 |
|
mannose-binding lectin - blood - genetics - metabolism |
4 |
|
mannose-binding lectin - immunology - metabolism |
4 |
|
mannose-binding lectins |
4 |
|
melamine |
4 |
|
methicillin-resistant staphylococcus aureus - classification - drug effects - genetics - isolation and purification |
4 |
|
milk |
4 |
|
mixed chimerism |
4 |
|
molecular basis of mendelian disorders |
4 |
|
monocytes - cytology |
4 |
|
monocytes - cytology - enzymology |
4 |
|
mrsa |
4 |
|
nalidixic acid - pharmacology |
4 |
|
neoplasms, multiple primary - diagnosis - pathology - therapy |
4 |
|
neural crest |
4 |
|
neuroectodermal tumors, primitive, peripheral - diagnosis - pathology - therapy |
4 |
|
neurofibromatosis |
4 |
|
neurofibromatosis 1 - diagnosis - pathology - therapy |
4 |
|
neutropenia |
4 |
|
neutropenia - epidemiology - ethnology |
4 |
|
nk cell |
4 |
|
nose - microbiology |
4 |
|
nuclear family |
4 |
|
nursing care |
4 |
|
ofloxacin - pharmacology |
4 |
|
oral poliovirus vaccine |
4 |
|
orthomyxoviridae infections - immunology - metabolism - pathology - virology |
4 |
|
p.r778l founder mutation |
4 |
|
p21 |
4 |
|
paediatric |
4 |
|
parental responses |
4 |
|
pediatric intensive care units |
4 |
|
peritonitis - blood - complications - genetics |
4 |
|
pneumococcal infections - epidemiology - microbiology |
4 |
|
pneumococcal vaccines - administration and dosage - immunology |
4 |
|
point mutation - genetics |
4 |
|
polymorphism |
4 |
|
population-based linkage |
4 |
|
primary liver tumours |
4 |
|
primitive neuroectodermal tumor |
4 |
|
puberty, delayed |
4 |
|
public health |
4 |
|
purpura, thrombocytopenic, idiopathic - drug therapy - etiology |
4 |
|
rare variants |
4 |
|
recessive mutation |
4 |
|
recurrence |
4 |
|
replicative potential |
4 |
|
resource needs |
4 |
|
respiratory syncytial virus infections - epidemiology |
4 |
|
respiratory tract infections - epidemiology |
4 |
|
rna |
4 |
|
rna, messenger - metabolism |
4 |
|
rotavirus |
4 |
|
sars virus - genetics - metabolism |
4 |
|
serotype |
4 |
|
severe combined immunodeficiency - pathology - therapy |
4 |
|
skin prick test |
4 |
|
social disparity |
4 |
|
standard of care |
4 |
|
staphylococcal infections - epidemiology - microbiology |
4 |
|
staphylococcus aureus |
4 |
|
status asthmaticus |
4 |
|
stomach neoplasms - complications - diagnosis |
4 |
|
streptococcus pneumoniae - classification - drug effects - isolation and purification |
4 |
|
streptococcus pneumoniae - drug effects |
4 |
|
t-box domain proteins - immunology |
4 |
|
t-lymphocyte subsets - immunology |
4 |
|
t-lymphocytes, regulatory - immunology |
4 |
|
t-lymphocytes, regulatory - immunology - pathology - secretion |
4 |
|
telomerase |
4 |
|
telomerase - metabolism |
4 |
|
th1 |
4 |
|
thalassemia |
4 |
|
training |
4 |
|
transplantation, homologous - adverse effects - immunology - methods |
4 |
|
treg |
4 |
|
uric acid |
4 |
|
urinary stones |
4 |
|
varicella |
4 |
|
wilson disease |
4 |
|
x-linked agammaglobulinemia |
4 |
|
y chromosome |
4 |
|
β-thalassemia |
4 |
|
*chromosome deletion |
3 |
|
*polymorphism, restriction fragment length |
3 |
|
12) (q11 |
3 |
|
5' untranslated regions - genetics |
3 |
|
abscess |
3 |
|
acinic cell carcinoma |
3 |
|
acute leukaemia |
3 |
|
acute lymphoblastic leukaemia |
3 |
|
acute promyelocytic leukaemia |
3 |
|
adaptive immunity |
3 |
|
adoptive transfer |
3 |
|
all |
3 |
|
all-trans retinoic acid |
3 |
|
alternative splicing |
3 |
|
amino acid conservation |
3 |
|
amino acid metabolism, inborn errors - blood - immunology |
3 |
|
amino acids - analysis |
3 |
|
anaplastic lymphoma (間變性淋巴瘤) |
3 |
|
antenatal screening |
3 |
|
anti-nmda receptor encephalitis |
3 |
|
antibodies, antinuclear - blood - immunology |
3 |
|
antifungal agents - therapeutic use |
3 |
|
antigens, cd |
3 |
|
antigens, cd - blood |
3 |
|
antigens, surface - genetics |
3 |
|
antineoplastic combined chemotherapy protocols - administration & dosage |
3 |
|
apoptosis regulatory proteins |
3 |
|
apoptosis- |
3 |
|
apoptosis-regulatory-proteins-biosynthesis |
3 |
|
apoptotic cells |
3 |
|
arthritis, rheumatoid - ethnology - genetics |
3 |
|
arthritis, rheumatoid - genetics |
3 |
|
arthritis, rheumatoid - immunology - metabolism |
3 |
|
asian continental ancestry group/*genetics |
3 |
|
asparaginase - adverse effects |
3 |
|
bacteremia - epidemiology - prevention & control |
3 |
|
bacterial infections - ethnology - immunology |
3 |
|
bacterial toxins - pharmacology |
3 |
|
bacterial typing techniques |
3 |
|
becker muscular dystrophy |
3 |
|
beta-thalassemia - blood - epidemiology - genetics |
3 |
|
blotting, southern |
3 |
|
bone (骨) |
3 |
|
bone marrow - immunology |
3 |
|
bone marrow cells - virology |
3 |
|
bone marrow transplant |
3 |
|
bone marrow transplantation - immunology |
3 |
|
bone neoplasms - drug therapy - epidemiology - pathology - surgery |
3 |
|
brain neoplasms - drug therapy - pathology |
3 |
|
brcc3 |
3 |
|
breastfeeding |
3 |
|
breg |
3 |
|
btk mutations |
3 |
|
burkitt lymphoma - epidemiology - immunology |
3 |
|
carcinoma - genetics - pathology |
3 |
|
cd4-positive t-lymphocytes - immunology - metabolism |
3 |
|
cd40l |
3 |
|
cell differentiation |
3 |
|
cell differentiation - immunology |
3 |
|
cell nucleus - genetics |
3 |
|
cell proliferation - drug effects |
3 |
|
cerebral thrombosis |
3 |
|
chemokines-biosynthesis |
3 |
|
chickenpox |
3 |
|
childhood acute lymphoblastic leukaemia |
3 |
|
childhood all |
3 |
|
childhood leukaemia |
3 |
|
children (兒童) |
3 |
|
children cancer |
3 |
|
children, chinese |
3 |
|
china - ethnology |
3 |
|
chromatography, gas |
3 |
|
chromatography, high pressure liquid |
3 |
|
chromosomes, human, pair 12 - genetics |
3 |
|
chromosomes, human, pair 15 |
3 |
|
chromosomes, human, pair 19 |
3 |
|
clinical genetics and dysmorphology |
3 |
|
clone cells |
3 |
|
clustering |
3 |
|
coding mutation |
3 |
|
collectins |
3 |
|
common infections |
3 |
|
comorbidity |
3 |
|
complement deficiency |
3 |
|
component resolved diagnostics |
3 |
|
congenital malformations |
3 |
|
conserved sequence |
3 |
|
corticotropin-releasing hormone - genetics |
3 |
|
cranial irradiation |
3 |
|
cytokines - biosynthesis |
3 |
|
cytokines - blood |
3 |
|
cytotoxic t-lymphocytes precursor frequency |
3 |
|
day care - statistics & numerical data |
3 |
|
dendritic cells - immunology - metabolism - pathology |
3 |
|
dendritic cells - immunology - metabolism - pathology - virology |
3 |
|
densitometry/methods |
3 |
|
deubiquitinase |
3 |
|
diploidy |
3 |
|
disease models, animal |
3 |
|
disease susceptibility - ethnology - immunology |
3 |
|
disease susceptibility - immunology |
3 |
|
disease-free survival |
3 |
|
dna primers - chemistry |
3 |
|
dna, neoplasm - genetics |
3 |
|
drug resistance, bacterial - genetics |
3 |
|
drug-exposed infants |
3 |
|
duchenne muscular dystrophy |
3 |
|
dying cells |
3 |
|
dyskeratosis congenita |
3 |
|
early-onset bronchiectasis |
3 |
|
eczema |
3 |
|
efficacy |
3 |
|
eif-2 kinase - immunology - metabolism |
3 |
|
epidermal growth factor - genetics |
3 |
|
epstein-barr virus |
3 |
|
essential thrombocythaemia |
3 |
|
european continental ancestry group |
3 |
|
evolutionary distance |
3 |
|
exacerbations |
3 |
|
exome sequencing |
3 |
|
exons |
3 |
|
expressed sequence tags |
3 |
|
false positive reactions |
3 |
|
fanconi anaemia |
3 |
|
fbn1 |
3 |
|
fetal blood - cytology - immunology - metabolism |
3 |
|
fetal hemoglobin - analysis |
3 |
|
fish |
3 |
|
fluoroquinolones - pharmacology |
3 |
|
formalin |
3 |
|
foscarnet |
3 |
|
functional impact |
3 |
|
functional polymorphism |
3 |
|
fungal infection |
3 |
|
ganciclovir |
3 |
|
gene expression regulation - drug effects |
3 |
|
gene mutations |
3 |
|
genetic association studies |
3 |
|
genetic diseases, x-linked - genetics |
3 |
|
genetic linkage |
3 |
|
genetics |
3 |
|
genome, human |
3 |
|
genotype-phenotype correlation |
3 |
|
germ cell tumour |
3 |
|
graft vs host disease - immunology |
3 |
|
graft-versus-host disease |
3 |
|
granulomatous disease, chronic - immunology |
3 |
|
haematopoietic stem cell transplant |
3 |
|
haemophilus influenzae |
3 |
|
haemophilus influenzae type b |
3 |
|
haploidy |
3 |
|
haplotypes - genetics |
3 |
|
helper t-cell precursor frequency |
3 |
|
hematopoietic stem cell transplant |
3 |
|
hemorrhage - etiology |
3 |
|
hemorrhagic cystitis |
3 |
|
hepatitis b - etiology - mortality |
3 |
|
hepatitis b antibodies - analysis |
3 |
|
hepatitis b surface antigens - analysis - immunology |
3 |
|
hepatomegaly - etiology |
3 |
|
hhv 6 |
3 |
|
high-speed video microscopy |
3 |
|
histocompatibility antigens class i - analysis |
3 |
|
histocompatibility antigens class ii - analysis |
3 |
|
homozygous c4b deficiency |
3 |
|
hospital records |
3 |
|
hyper-ige |
3 |
|
hyperdiploid |
3 |
|
hyperimmunoglobulin e syndrome |
3 |
|
ibd |
3 |
|
ifn-γ-producing cell frequency |
3 |
|
il-33 |
3 |
|
immune reconstitution |
3 |
|
immunity, innate - immunology |
3 |
|
immunization schedule |
3 |
|
immunocompromised host - immunology |
3 |
|
immunohistochemistry |
3 |
|
immunologic deficiency syndromes - complications - immunology |
3 |
|
immunophenotype |
3 |
|
immunosuppressant |
3 |
|
immunosuppressive agents - therapeutic use |
3 |
|
inborn error of immunity |
3 |
|
infection - diagnosis - epidemiology - genetics - physiopathology |
3 |
|
infection - epidemiology |
3 |
|
influenza a virus - chemistry - immunology |
3 |
|
influenza a virus, h5n1 subtype - chemistry - immunology |
3 |
|
influenza-a-virus,-h1n1-subtype-immunology |
3 |
|
influenza-a-virus,-h5n1-subtype-immunology |
3 |
|
influenza-a-virus,-h5n1-subtype-pathogenicity |
3 |
|
influenza-a-virus,-h9n2-subtype-immunology |
3 |
|
inheritance patterns |
3 |
|
insulin-like growth factor i - physiology |
3 |
|
intensive care |
3 |
|
interferon-gamma - biosynthesis |
3 |
|
interferon-gamma - pharmacology |
3 |
|
interleukin 12 |
3 |
|
interleukin-10 - deficiency - physiology |
3 |
|
interleukin-10 - genetics |
3 |
|
interleukin-12 receptor beta 1 subunit - deficiency - genetics |
3 |
|
interleukin-17 - biosynthesis - genetics |
3 |
|
interleukin-6 - biosynthesis |
3 |
|
international classification of diseases |
3 |
|
intracellular signaling peptides and proteins |
3 |
|
intracranial |
3 |
|
intrathecal |
3 |
|
intrauterine growth retardation |
3 |
|
intussusception - epidemiology |
3 |
|
iron chelation therapy |
3 |
|
isaac |
3 |
|
job syndrome |
3 |
|
josd2 |
3 |
|
jurkat cells |
3 |
|
juvenile pernicious anaemia |
3 |
|
k-deleting recombination excision circles |
3 |
|
kidney - immunology - pathology |
3 |
|
killer cells, natural - immunology |
3 |
|
kw042 - diagnostics |
3 |
|
kw085 - haplotype |
3 |
|
kw141 - population genetics |
3 |
|
kw154 - respiratory system |
3 |
|
kw160 - snp analysis/discovery |
3 |
|
l-asparaginase |
3 |
|
lactation |
3 |
|
leukemia - epidemiology |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics |
3 |
|
leukemia, myelomonocytic, chronic - genetics |
3 |
|
leukemia-lymphoma, adult t-cell - epidemiology - immunology |
3 |
|
leukocytes, mononuclear - metabolism |
3 |
|
life tables |
3 |
|
limiting dilution assay |
3 |
|
linkage (genetics)/*genetics |
3 |
|
lod score |
3 |
|
lupus erythematosus, systemic - blood - complications - drug therapy - ethnology |
3 |
|
lymphocyte subsets - immunology |
3 |
|
macrophages-immunology |
3 |
|
macrophages-virology |
3 |
|
magnetic resonance imaging |
3 |
|
mannose-binding lectin - blood - genetics |
3 |
|
mannose-binding protein |
3 |
|
marfan syndrome |
3 |
|
marfan syndrome - genetics |
3 |
|
mediastinal neoplasms - genetics - pathology |
3 |
|
membrane-glycoproteins-biosynthesis |
3 |
|
meningitis, pneumococcal - epidemiology - prevention & control |
3 |
|
mesenchymal stem cells |
3 |
|
mesenchymal stem cells - cytology - drug effects - metabolism |
3 |
|
mesenchymal stem cells - cytology - immunology |
3 |
|
mesenchymal stem cells - drug effects - immunology |
3 |
|
method |
3 |
|
methotrexate - administration & dosage |
3 |
|
methylmalonic acid - blood |
3 |
|
methylmalonic acidaemia |
3 |
|
mice, inbred mrl lpr |
3 |
|
mice, knockout |
3 |
|
mice, transgenic - genetics |
3 |
|
microfilament proteins - genetics |
3 |
|
microinjections - methods |
3 |
|
microsatellite repeats |
3 |
|
monocytes - immunology - microbiology |
3 |
|
mucosal inflammation |
3 |
|
multidisciplianry care |
3 |
|
multigene family/*genetics |
3 |
|
multiple intestinal atresias (mia) |
3 |
|
muscular dystrophies/*genetics |
3 |
|
mutation screening |
3 |
|
mutation/genetics |
3 |
|
mutations |
3 |
|
mycobacterium infections - genetics |
3 |
|
mycobacterium infections - immunology |
3 |
|
mycoses - diagnosis - drug therapy - immunology - microbiology |
3 |
|
myeloperoxidase deficiency |
3 |
|
myeloproliferation |
3 |
|
near-haploid |
3 |
|
necrosis |
3 |
|
neoplasm metastasis |
3 |
|
newborn screening |
3 |
|
nlrp3 |
3 |
|
nod2 signaling adaptor protein |
3 |
|
non-aids |
3 |
|
non-hiv |
3 |
|
nosocomial transmission |
3 |
|
nssnp |
3 |
|
opportunistic infections - genetics - immunology |
3 |
|
osteoblasts - cytology |
3 |
|
osteogenesis - immunology |
3 |
|
osteogenic differentiation |
3 |
|
osteosarcoma |
3 |
|
osteosarcoma - drug therapy - epidemiology - pathology - surgery |
3 |
|
outbreak |
3 |
|
outcome |
3 |
|
pain - etiology |
3 |
|
pancreatitis |
3 |
|
pancreatitis - chemically induced - drug therapy |
3 |
|
peanut allergy |
3 |
|
penicillium - classification - isolation & purification |
3 |
|
phagocytes - physiology |
3 |
|
phagocytosis - immunology |
3 |
|
phytohemagglutinins - antagonists & inhibitors - pharmacology |
3 |
|
pineal gland |
3 |
|
plasmapheresis |
3 |
|
platelet count |
3 |
|
pneumatocoele |
3 |
|
pneumococcal disease |
3 |
|
pneumococcal infections - epidemiology - prevention & control |
3 |
|
pneumococcal vaccines - administration & dosage |
3 |
|
pneumocystis carinii pneumonia |
3 |
|
pneumonia, pneumococcal - epidemiology - prevention & control |
3 |
|
population mixing |
3 |
|
postoperative period |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - blood - drug therapy - epidemiology - pathology - radiotherapy |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - drug therapy |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - epidemiology |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - epidemiology - immunology |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics |
3 |
|
pregnancy |
3 |
|
preterm infants |
3 |
|
primary ciliary dyskinesia |
3 |
|
primary immunodeficiency |
3 |
|
primary immunodeficiency disorders |
3 |
|
programmed cell death 1 receptor |
3 |
|
pronuclear microinjection |
3 |
|
protein-tyrosine kinases - genetics - immunology |
3 |
|
proteinuria - immunology - pathology |
3 |
|
q13) |
3 |
|
questionnaires |
3 |
|
rank ligand - biosynthesis |
3 |
|
rapid |
3 |
|
receptors, ccr1 - genetics - immunology - metabolism |
3 |
|
receptors, ccr3 - genetics - immunology - metabolism |
3 |
|
receptors, ccr5 - genetics - immunology - metabolism |
3 |
|
receptors, transforming growth factor beta - genetics |
3 |
|
reference interval |
3 |
|
regulatory b cell |
3 |
|
remission induction |
3 |
|
residence characteristics - statistics & numerical data |
3 |
|
respiratory burst |
3 |
|
restriction fragment length polymorphism |
3 |
|
rheumatoid arthritis |
3 |
|
rna - genetics |
3 |
|
rna, messenger - biosynthesis |
3 |
|
rna-binding proteins - genetics |
3 |
|
safety |
3 |
|
salivary gland |
3 |
|
sars virus - immunology - pathogenicity |
3 |
|
scoring system |
3 |
|
second cancer |
3 |
|
selective iga deficiency |
3 |
|
sepsis - complications |
3 |
|
sequence alignment |
3 |
|
sequence homology, amino acid |
3 |
|
serotype replacement |
3 |
|
severe acute respiratory syndrome (sars) |
3 |
|
severe combined immunodeficiency (scid) |
3 |
|
severe congenital neutropenia |
3 |
|
sex factors |
3 |
|
signal transducer and activator of transcription 3 |
3 |
|
social conditions - statistics & numerical data |
3 |
|
somatostatin |
3 |
|
somatostatin - therapeutic use |
3 |
|
splenomegaly - etiology |
3 |
|
stat1 |
3 |
|
streptococcus pneumoniae - classification - drug effects |
3 |
|
streptococcus pneumoniae - classification - drug effects - immunology - isolation and purification |
3 |
|
subcutaneous needle |
3 |
|
sweden |
3 |
|
synteny |
3 |
|
t cell dysfunction |
3 |
|
t cell receptor excision circles |
3 |
|
t helper 17 cells |
3 |
|
t(9 |
3 |
|
t-lymphocytes - cytology - immunology - metabolism - physiology |
3 |
|
t-lymphocytes, helper-inducer - immunology |
3 |
|
t-lymphocytes, regulatory - drug effects - immunology |
3 |
|
taloromyces marneffei |
3 |
|
teratology |
3 |
|
teratoma |
3 |
|
teratoma - drug therapy - pathology |
3 |
|
tgfbr2 |
3 |
|
thalassaemia |
3 |
|
thalassemia - therapy |
3 |
|
thrombocytosis |
3 |
|
thrombocytosis - diagnosis |
3 |
|
thymic neoplasm |
3 |
|
toll-like receptor 7 - genetics |
3 |
|
transgenic mice |
3 |
|
transient immunodeficiency |
3 |
|
translocation |
3 |
|
transmission electron microscopy |
3 |
|
treatment |
3 |
|
trigger |
3 |
|
ttc7a |
3 |
|
tuberculosis - immunology |
3 |
|
type i |
3 |
|
u937 cells |
3 |
|
unnecessary procedures |
3 |
|
vaccines, conjugate - administration & dosage |
3 |
|
veoibd |
3 |
|
viral infection |
3 |
|
vitiligo |
3 |
|
wasp |
3 |
|
whole exome sequencing |
3 |
|
whole exome sequencing (wes) |
3 |
|
x-linked combined immunodeficiency diseases - diagnosis - epidemiology - genetics - physiopathology |
3 |
|
x-linked hyper-igm syndrome |
3 |
|
x-linked lymphoproliferative disease type 1 (xlp1) |
3 |
|
xla |
3 |
|
zebrafish - genetics |
3 |
|
absolute lymphocyte count |
2 |
|
acetaminophen - administration & dosage - adverse effects |
2 |
|
acremonium - isolation & purification |
2 |
|
acute lymphobiastic leukaemia |
2 |
|
acute myeloid leukemia |
2 |
|
acyclovir |
2 |
|
adult-onset type ii citrullinemia (ctln2) |
2 |
|
african continental ancestry group - genetics |
2 |
|
allergic rhinitis |
2 |
|
allergic thiniris |
2 |
|
alpha-thalassemia-epidemiology |
2 |
|
amphotericin b |
2 |
|
analgesics, non-narcotic - adverse effects - analysis |
2 |
|
analysis of variance |
2 |
|
anaphylaxis - chemically induced - physiopathology |
2 |
|
anemia, aplastic - complications - drug therapy |
2 |
|
anti-cd20 monoclonal antibody |
2 |
|
anti-infective agents - therapeutic use |
2 |
|
anti-retroviral agents - therapeutic use |
2 |
|
antibody formation |
2 |
|
antigen-antibody complex - genetics - immunology |
2 |
|
antigens, cd - deficiency |
2 |
|
antigens, cd18 |
2 |
|
antigens, cd45 - genetics - immunology - metabolism |
2 |
|
antigens, cd95 - genetics - immunology - metabolism |
2 |
|
antiretroviral therapy, highly active - methods - trends |
2 |
|
apde |
2 |
|
arterial stiffness |
2 |
|
arteries |
2 |
|
asian primary immunodeficiency network |
2 |
|
aspartate-glutamate carrier (agc) |
2 |
|
association studies |
2 |
|
asthma - epidemiology |
2 |
|
atopic eczema |
2 |
|
b-lymphocytes - cytology - physiology |
2 |
|
bacteremia |
2 |
|
bacteremia - diagnosis - drug therapy - etiology |
2 |
|
bacteremia - etiology |
2 |
|
bacterial septicaemia |
2 |
|
barley |
2 |
|
beta-thalassemia - surgery |
2 |
|
beta-thalassemia-epidemiology |
2 |
|
biomarker |
2 |
|
biopsy |
2 |
|
blood transfusion |
2 |
|
bone marrow transplantation - methods |
2 |
|
bupivacaine |
2 |
|
c-reactive protein - genetics - metabolism |
2 |
|
canakinumab |
2 |
|
candidiasis |
2 |
|
carbon monoxide |
2 |
|
cardiac surgical procedures - adverse effects |
2 |
|
carotid artery, common - physiopathology - ultrasonography |
2 |
|
carrier frequency |
2 |
|
case control study |
2 |
|
catheter-associated infection |
2 |
|
catheterization, peripheral - adverse effects |
2 |
|
ccl2 |
2 |
|
cd34 + cells |
2 |
|
cdna sequencing |
2 |
|
cell adhesion |
2 |
|
cell signaling |
2 |
|
cellulitis - microbiology |
2 |
|
chemokine ccl5 - genetics |
2 |
|
chemokines - genetics |
2 |
|
chi-square distribution |
2 |
|
chickenpox - prevention & control |
2 |
|
chickenpox vaccine |
2 |
|
chloroprocaine |
2 |
|
chromobacterium violaceum |
2 |
|
chromosomal mapping |
2 |
|
chronic granulomatous disease |
2 |
|
chronic itp |
2 |
|
ciprofloxacin - therapeutic use |
2 |
|
citrin |
2 |
|
classification |
2 |
|
clostridium - isolation & purification |
2 |
|
clostridium clostridiiforme |
2 |
|
clostridium infections - etiology |
2 |
|
collagen - genetics |
2 |
|
communicable diseases |
2 |
|
complex diseases |
2 |
|
convulsion |
2 |
|
cord blood |
2 |
|
cryopyrin-associated periodic syndrome |
2 |
|
cybb |
2 |
|
cytokines - genetics |
2 |
|
cytotoxicity, immunologic - immunology |
2 |
|
d7s1812 |
2 |
|
data collection |
2 |
|
database |
2 |
|
delayed-type hypersensitivity |
2 |
|
dendritic cell |
2 |
|
desensitization |
2 |
|
diagnosis |
2 |
|
dideoxynucleosides - therapeutic use |
2 |
|
dna - genetics |
2 |
|
dna, viral - analysis |
2 |
|
dose-response relationship, immunologic |
2 |
|
dyskeratosis congenita - therapy |
2 |
|
east asian |
2 |
|
eczema - epidemiology |
2 |
|
education, medical, continuing |
2 |
|
elasticity |
2 |
|
empyema |
2 |
|
empyema, pleural - microbiology |
2 |
|
endocytosis |
2 |
|
eosinophilia |
2 |
|
epilepsygene expression |
2 |
|
erythrocyte indices |
2 |
|
evaluation studies |
2 |
|
expressed sequence tag |
2 |
|
extramedullary hematopoiesis |
2 |
|
family history |
2 |
|
fanconi anemia - therapy |
2 |
|
fetal diseases - genetics |
2 |
|
fluorescent antibody technique |
2 |
|
follow up |
2 |
|
follow-up studies |
2 |
|
food allergy |
2 |
|
ganoderma lucidum |
2 |
|
gastrointestinal diseases |
2 |
|
gene deletion |
2 |
|
gene dosage |
2 |
|
gene dosage - genetics - immunology |
2 |
|
gene expression regulation - genetics |
2 |
|
gene expression regulation - genetics - immunology |
2 |
|
gene polymorphism |
2 |
|
gene polymorphisms |
2 |
|
generalized reaction |
2 |
|
genes (基因) |
2 |
|
genetic association study |
2 |
|
genetic counselling |
2 |
|
genetic predisposition to disease - ethnology - genetics |
2 |
|
genetic predisposition to disease - genetics |
2 |
|
genetic susceptibility |
2 |
|
genetic variation |
2 |
|
genetic variation - immunology |
2 |
|
genetic-predisposition-to-disease |
2 |
|
genome scan |
2 |
|
genotype and phenotype correlation |
2 |
|
genotype-phenotype correlations |
2 |
|
globin gene mutation |
2 |
|
glomerulonephritis, membranous - complications - drug therapy - epidemiology |
2 |
|
graft survival - drug effects |
2 |
|
gram-negative bacterial infections - diagnosis - drug therapy - etiology |
2 |
|
granulocyte-macrophage colony-stimulating factor - therapeutic use |
2 |
|
granulomatous disease, chronic - ethnology - genetics |
2 |
|
growth disorders - blood |
2 |
|
growth hormone |
2 |
|
growth hormone - deficiency |
2 |
|
growth hormone deficiency |
2 |
|
guillain-barre syndrome |
2 |
|
haemolysis |
2 |
|
haemopoietic primitive cell |
2 |
|
health policy |
2 |
|
health services research |
2 |
|
hematopoiesis, extramedullary |
2 |
|
hemosiderosis |
2 |
|
hepatitis - complications - drug therapy |
2 |
|
hepatitis b - complications - drug therapy - epidemiology |
2 |
|
hepatitis b e antigens - analysis |
2 |
|
hepatitis b surface antigens - blood |
2 |
|
hepatitis b vaccines - immunology |
2 |
|
hepatitis b virus - genetics |
2 |
|
hepatitis b virus infection |
2 |
|
herpes zoster |
2 |
|
herpes zoster - prevention & control |
2 |
|
herpesviridae infections - complications - drug therapy |
2 |
|
herpesvirus 3, human - immunology |
2 |
|
herpesvirus 4, human - isolation & purification |
2 |
|
hiv infections - blood - drug therapy |
2 |
|
human dendritic cell |
2 |
|
human serum albumin |
2 |
|
hydrops fetalis |
2 |
|
hydrops fetalis - genetics - prevention & control |
2 |
|
ifn-γ |
2 |
|
iga nephropathy |
2 |
|
ige |
2 |
|
immune system |
2 |
|
immune tolerance - immunology |
2 |
|
immunodeficiencies |
2 |
|
immunologic deficiency syndromes - epidemiology - genetics |
2 |
|
immunologic deficiency syndromes - epidemiology - genetics - immunology |
2 |
|
immunomodulation |
2 |
|
immunosuppression - adverse effects |
2 |
|
infant, low birth weight |
2 |
|
infant, premature - immunology |
2 |
|
infections |
2 |
|
infectious disease |
2 |
|
information dissemination |
2 |
|
insulin-like growth factor |
2 |
|
insulin-like growth factor i - immunology - metabolism |
2 |
|
integrative analysis |
2 |
|
interferon gamma |
2 |
|
interferon-gamma - genetics |
2 |
|
interferon-type-ii-genetics |
2 |
|
interferons - therapeutic use |
2 |
|
interleukin-6 - immunology - metabolism |
2 |
|
interprofessional relations |
2 |
|
irf3 |
2 |
|
juvenile idiopathic arthritis |
2 |
|
juvenile-onset |
2 |
|
kawasaki disease |
2 |
|
ketamine |
2 |
|
kidney - pathology |
2 |
|
left ventricle |
2 |
|
leukemia - immunology |
2 |
|
leukemia, promyelocytic, acute - therapy |
2 |
|
leukocyte-adhesion deficiency syndrome |
2 |
|
lfa-1 |
2 |
|
lidocaine |
2 |
|
lignocaine |
2 |
|
listeria monocytogenes |
2 |
|
listeriosis - etiology |
2 |
|
local anaesthetic |
2 |
|
lung diseases - complications |
2 |
|
lupus erythematosus, systemic - genetics - metabolism |
2 |
|
lymphoblastic leukaemia |
2 |
|
lymphocytes |
2 |
|
lymphocytes - immunology |
2 |
|
lymphoma |
2 |
|
mac-1 |
2 |
|
macrophage activation syndrome (巨噬细胞活化综合征) |
2 |
|
macrophage-1 antigen - deficiency |
2 |
|
mass screening |
2 |
|
mass screening - methods |
2 |
|
mass screening - utilization |
2 |
|
maternal plasma |
2 |
|
mbl |
2 |
|
mch |
2 |
|
mcv |
2 |
|
mean corpuscular volume |
2 |
|
measles |
2 |
|
melioidosis |
2 |
|
membrane glycoproteins - chemistry - genetics |
2 |
|
membranous nephropathy |
2 |
|
memory t cells |
2 |
|
micrornas - genetics - metabolism |
2 |
|
midazolam |
2 |
|
missing heritability |
2 |
|
mixed lymphocyte reaction |
2 |
|
molecular diagnosis |
2 |
|
monocyte |
2 |
|
mucocutaneous lymph node syndrome - blood - epidemiology - genetics |
2 |
|
mutation analysis |
2 |
|
mutation detection |
2 |
|
mycobacterial infections |
2 |
|
mycobacterium bovis - isolation & purification |
2 |
|
mycobacterium infections, nontuberculous - epidemiology - genetics |
2 |
|
mycobacterium tuberculosis - isolation & purification |
2 |
|
mycoses - complications - drug therapy |
2 |
|
nasopharyngeal carcinoma |
2 |
|
nephritis, hereditary |
2 |
|
nephrotic syndrome - immunology |
2 |
|
network |
2 |
|
neutropaenic colitis |
2 |
|
neutrophils - immunology |
2 |
|
nfκb |
2 |
|
ngs |
2 |
|
nk cells |
2 |
|
nocardia infections - transmission |
2 |
|
nocardia otitidis coviarum |
2 |
|
nontuberculous mycobacteria - isolation & purification |
2 |
|
oka |
2 |
|
oka-rit |
2 |
|
oncology |
2 |
|
osteocalcin |
2 |
|
osteocalcin - blood |
2 |
|
paralysis |
2 |
|
paralysis - diagnosis - economics - epidemiology |
2 |
|
parental atopy |
2 |
|
perinatal human immunodeficiency virus infection |
2 |
|
plaque-forming cells |
2 |
|
platelet dysfunction |
2 |
|
platelets |
2 |
|
pleiotropy |
2 |
|
plesiomonas shigelloides |
2 |
|
poliomyelitis |
2 |
|
polymorphism, restriction fragment length |
2 |
|
polymorphism,-single-nucleotide |
2 |
|
polysaccharides |
2 |
|
population differences |
2 |
|
population genetics |
2 |
|
population structure |
2 |
|
postoperative complications |
2 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics - immunology |
2 |
|
predictive value of tests |
2 |
|
prenatal diagnosis |
2 |
|
primary health care |
2 |
|
primary immunodeficiency disorder |
2 |
|
product surveillance, postmarketing |
2 |
|
protein-protein interactions |
2 |
|
radioimmunoassay |
2 |
|
randomized controlled trials as topic |
2 |
|
rast |
2 |
|
reactivity |
2 |
|
receptors, igg - genetics |
2 |
|
recombinant proteins - therapeutic use |
2 |
|
red cell indices |
2 |
|
referral and consultation |
2 |
|
refuges |
2 |
|
regional health planning |
2 |
|
replication |
2 |
|
research |
2 |
|
research (研究) |
2 |
|
rhinitis |
2 |
|
rhinitis, allergic, perennial - epidemiology |
2 |
|
rituximab |
2 |
|
school air quality |
2 |
|
scid |
2 |
|
screening |
2 |
|
sedation |
2 |
|
selection |
2 |
|
sentinel surveillance |
2 |
|
septicemia |
2 |
|
sequence-specific subtraction |
2 |
|
sequencing depth |
2 |
|
severe acute respiratory syndrome - genetics |
2 |
|
severe-acute-respiratory-syndrome-genetics |
2 |
|
sex (性) |
2 |
|
shared genes |
2 |
|
shigellosis |
2 |
|
short inversion detection |
2 |
|
short stature |
2 |
|
signal transduction - immunology |
2 |
|
single-nucleotide polymorphisms |
2 |
|
skeletal complication |
2 |
|
slc25a13 |
2 |
|
sle damage index |
2 |
|
sociology, medical |
2 |
|
somatic mosaicism mutation |
2 |
|
spinal cord compression |
2 |
|
spinal cord compression - etiology - therapy |
2 |
|
split reads method |
2 |
|
stat3 |
2 |
|
structural variations |
2 |
|
subcutaneous cellulitis |
2 |
|
surgical wound infection - microbiology |
2 |
|
t cell receptor excision circle |
2 |
|
t cells |
2 |
|
t-cell mediated |
2 |
|
t-lymphocytes - cytology - physiology |
2 |
|
thailand - epidemiology |
2 |
|
thalassaemia major |
2 |
|
thalassemia - blood - diagnosis |
2 |
|
thalassemia - diagnosis - epidemiology - genetics |
2 |
|
thalassemia screening |
2 |
|
therapeutic use |
2 |
|
thrombocytopenia |
2 |
|
tolerance |
2 |
|
transcription factor |
2 |
|
transfusion |
2 |
|
transplant |
2 |
|
tuberculosis |
2 |
|
tumor necrosis factor-alpha - blood - genetics |
2 |
|
tyk2 kinase - genetics |
2 |
|
ultrasonography |
2 |
|
umbilical cord blood |
2 |
|
under-5s mortality |
2 |
|
urban population |
2 |
|
urolithiasis |
2 |
|
vaccines |
2 |
|
varilrix |
2 |
|
vascular resistance - physiology |
2 |
|
vibrionaceae - classification - isolation & purification |
2 |
|
vietnamese |
2 |
|
was |
2 |
|
wheeze |
2 |
|
whole-exome sequencing |
2 |
|
wiskott-aldrich syndrome - genetics - immunology - pathology |
2 |
|
x chromosome - genetics |
2 |
|
x-linked lymphoproliferative disease |
2 |
|
young children |
2 |
|
α-globin gene deletions |
2 |
|
3years |
1 |
|
abdominal muscles |
1 |
|
acute flaccid paralysis |
1 |
|
adenoviridae infections - microbiology |
1 |
|
adenovirus infections, human - microbiology |
1 |
|
adenoviruses, human - isolation & purification |
1 |
|
administration, intranasal |
1 |
|
adolescence |
1 |
|
adult onset still's disease |
1 |
|
agammaglobulinemia - complications - genetics |
1 |
|
agammaglobulinemia - genetics |
1 |
|
agammaglobulinemia - genetics - immunology |
1 |
|
air pollution |
1 |
|
albuterol - therapeutic use |
1 |
|
allergens - immunology |
1 |
|
allergy and immunology |
1 |
|
allergy testing |
1 |
|
anti-inflammatory agents, non-steroidal - therapeutic use |
1 |
|
antibodies - pharmacology |
1 |
|
antibodies, anti-idiotypic - blood - immunology |
1 |
|
antibodies, viral - analysis - biosynthesis |
1 |
|
antigens, cd - metabolism |
1 |
|
antigens, differentiation, b-lymphocyte - immunology |
1 |
|
antineoplastic combined chemotherapy protocols - adverse effects |
1 |
|
antineutrophil cytoplasmic antibody |
1 |
|
antitubercular agents - administration & dosage - therapeutic use |
1 |
|
aortic aneurysm |
1 |
|
ar-agammaglobulinemia |
1 |
|
arterial occlusive diseases - complications |
1 |
|
arthritis |
1 |
|
arthritis, juvenile rheumatoid - complications - drug therapy - immunology |
1 |
|
aspergillus fumigatus - genetics |
1 |
|
asthma - complications - drug therapy - immunology |
1 |
|
asthma - diagnosis |
1 |
|
autoantibodies - analysis |
1 |
|
autoantibodies - blood - immunology |
1 |
|
autoimmune disease |
1 |
|
autoimmune diseases - complications - immunology |
1 |
|
autoimmune diseases - immunology |
1 |
|
autologous transfusion |
1 |
|
b-lymphocytes |
1 |
|
bacillus calmette-guerin |
1 |
|
bacteremia in ventilated neonates |
1 |
|
bacterial infections - complications - prevention & control |
1 |
|
bacterial proteins - pharmacology |
1 |
|
bcg complications |
1 |
|
bcg osteomyelitis |
1 |
|
birc4 mutation |
1 |
|
blood platelets - pathology - ultrastructure |
1 |
|
bloodletting - adverse effects - psychology |
1 |
|
bnt162b2 vaccine |
1 |
|
brazil |
1 |
|
bronchopulmonary sequestration - pathology - surgery |
1 |
|
bruton tyrosine kinase |
1 |
|
c3 fragments |
1 |
|
callitrichinae |
1 |
|
candida albicans - growth & development - metabolism - pathogenicity |
1 |
|
candidate gene strategy |
1 |
|
cap-feia |
1 |
|
carrier proteins - analysis - genetics |
1 |
|
caucasian population |
1 |
|
cd18 gene |
1 |
|
cd4-positive t-lymphocytes - immunology |
1 |
|
cd4-positive t-lymphocytes - metabolism |
1 |
|
cefadroxil |
1 |
|
cefadroxil - pharmacology - therapeutic use |
1 |
|
cell analysis |
1 |
|
cell line |
1 |
|
cell line, transformed |
1 |
|
cell nucleus - metabolism |
1 |
|
cell transformation, viral |
1 |
|
chaperonin 60 |
1 |
|
chaperonins - pharmacology |
1 |
|
chickenpox - epidemiology - prevention & control |
1 |
|
chickenpox vaccine - adverse effects - genetics - immunology |
1 |
|
chickenpox vaccine - adverse effects - immunology |
1 |
|
child psychology |
1 |
|
chinese population |
1 |
|
chinese/caucasian populations |
1 |
|
chromosome disorders |
1 |
|
chromosome mapping |
1 |
|
chromosomes, human, pair 16 |
1 |
|
chromosomes, human, x |
1 |
|
cinca syndrome |
1 |
|
clotting proteins |
1 |
|
combined vaccines |
1 |
|
common opsonic defect |
1 |
|
common variable immunodeficiency |
1 |
|
complement c3b - analysis |
1 |
|
complement pathway, mannose-binding lectin |
1 |
|
conjunctivitis, allergic - epidemiology |
1 |
|
consanguinity |
1 |
|
corticosteroids |
1 |
|
cotrimoxazole |
1 |
|
covid-19 vaccines |
1 |
|
craniocerebral trauma - complications |
1 |
|
craniopharyngioma - complications - radiography |
1 |
|
cross-reactive antigens |
1 |
|
ctla-4 antigen |
1 |
|
cxcr4 |
1 |
|
cyclophosphamide - adverse effects |
1 |
|
cytokine storm |
1 |
|
cytomegalovirus |
1 |
|
cytoplasm - immunology |
1 |
|
cytosol - metabolism |
1 |
|
dactinomycin - adverse effects |
1 |
|
databases, factual |
1 |
|
dendritic cells - cytology - metabolism |
1 |
|
dendritic cells - immunology - metabolism |
1 |
|
dendritic cells - immunology - microbiology |
1 |
|
dendritic cells - physiology |
1 |
|
diarrhoea |
1 |
|
differential diagnosis |
1 |
|
disease outbreaks/prevention and control |
1 |
|
disease-outbreaks |
1 |
|
disseminated bcg |
1 |
|
dna - analysis |
1 |
|
dna - genetics - isolation & purification |
1 |
|
dna primers |
1 |
|
dock8 deficiency |
1 |
|
donor |
1 |
|
dosage compensation, genetic |
1 |
|
double-blind method |
1 |
|
drug incompatibility |
1 |
|
drug stability |
1 |
|
drug therapy, combination |
1 |
|
drug tolerance |
1 |
|
echovirus infections - microbiology |
1 |
|
eczema - diagnosis |
1 |
|
education |
1 |
|
enterovirus |
1 |
|
enterovirus b, human - isolation & purification |
1 |
|
environmental exposure - statistics & numerical data |
1 |
|
environmental illness - epidemiology |
1 |
|
epipen® |
1 |
|
erythema |
1 |
|
escherichia coli - isolation & purification |
1 |
|
escherichia coli infections - etiology |
1 |
|
etanercept |
1 |
|
ethics, medical |
1 |
|
european continental ancestry group - genetics |
1 |
|
exons - genetics |
1 |
|
factor v deficiency |
1 |
|
factor viii deficiency |
1 |
|
fear |
1 |
|
fetal blood - cytology |
1 |
|
fetal diseases - diagnosis |
1 |
|
fingers - surgery |
1 |
|
fluorescence in situ hybridization |
1 |
|
food habits |
1 |
|
foot diseases - complications - pathology |
1 |
|
gain-of-function mutation |
1 |
|
gallium index |
1 |
|
gallium lung scintiscan |
1 |
|
gallium radioisotopes - diagnostic use |
1 |
|
gambia |
1 |
|
gambian population |
1 |
|
gamma interferon |
1 |
|
gangrene |
1 |
|
gastric lavage |
1 |
|
gastroenteritis - prevention & control - virology |
1 |
|
genes, immunoglobulin |
1 |
|
genes, recessive |
1 |
|
genetic diseases, x-linked |
1 |
|
genetic markers |
1 |
|
global |
1 |
|
global health |
1 |
|
granulocyte colony stimulating factor |
1 |
|
granulomatous disease, chronic - diagnosis - ethnology - etiology - prevention & control |
1 |
|
granulomatous disease, chronic - diagnosis - genetics - immunology - physiopathology |
1 |
|
granulomatous disease, chronic - genetics |
1 |
|
granulomatous disease, chronic - genetics - microbiology |
1 |
|
great britain |
1 |
|
greenland |
1 |
|
haemarthrosis |
1 |
|
haemophilia |
1 |
|
hallux |
1 |
|
hand hygiene |
1 |
|
hemophilia |
1 |
|
hepatic veno-occlusive disease - chemically induced |
1 |
|
hepatitis b |
1 |
|
hepatitis b - prevention & control |
1 |
|
herpes simplex |
1 |
|
herpesvirus 4, human |
1 |
|
heterozygote detection |
1 |
|
heterozygote detection - methods |
1 |
|
histocompatibility antigens class ii - metabolism |
1 |
|
hiv |
1 |
|
hiv-exposed but uninfected |
1 |
|
hla antigens |
1 |
|
hla-a antigens - analysis |
1 |
|
hla-b antigens - analysis |
1 |
|
hla-dr antigens - analysis |
1 |
|
hospital admission |
1 |
|
human herpes-virus 6 |
1 |
|
human rotavirus vaccine |
1 |
|
hyper ige syndrome |
1 |
|
hypersensitivity - diagnosis |
1 |
|
hypersensitivity - immunology |
1 |
|
hypersensitivity, immediate - blood - classification - ethnology - immunology |
1 |
|
hypersensitivity, immediate - complications - ethnology |
1 |
|
hypersensitivity, immediate - immunology |
1 |
|
hypogammaglobulinaemia |
1 |
|
hypoxanthine phosphoribosyltransferase - analysis - genetics |
1 |
|
i-kappa b proteins - metabolism |
1 |
|
idiotype |
1 |
|
iei in sri lanka |
1 |
|
iga deficiency |
1 |
|
igg subclass deficiency |
1 |
|
igg subclasses |
1 |
|
igkv2-29 |
1 |
|
igkvd-29 |
1 |
|
il10 |
1 |
|
immunity, natural |
1 |
|
immunization programs |
1 |
|
immunoassay |
1 |
|
immunoassay - methods |
1 |
|
immunoglobulin a |
1 |
|
immunoglobulin a - analysis |
1 |
|
immunoglobulin class switching - physiology |
1 |
|
immunoglobulin e - biosynthesis |
1 |
|
immunoglobulin e - blood |
1 |
|
immunoglobulin e - immunology |
1 |
|
immunoglobulin g |
1 |
|
immunoglobulin g - analysis |
1 |
|
immunoglobulin g - blood - immunology |
1 |
|
immunoglobulin m |
1 |
|
immunoglobulin m - analysis |
1 |
|
immunologic deficiency syndromes |
1 |
|
immunologic deficiency syndromes - diagnosis - genetics |
1 |
|
immunologic deficiency syndromes - enzymology - genetics |
1 |
|
immunologic deficiency syndromes - genetics |
1 |
|
indel mutation |
1 |
|
indians, south american - genetics |
1 |
|
infant, premature |
1 |
|
influenza vaccines - administration & dosage - immunology |
1 |
|
influenza, human - prevention & control |
1 |
|
influenza-like illness |
1 |
|
inhalation |
1 |
|
interferon-gamma - metabolism |
1 |
|
interferon-gamma - physiology |
1 |
|
interleukin-10 - blood |
1 |
|
interleukin-12 - blood |
1 |
|
interleukin-4 |
1 |
|
interleukin-4 - metabolism |
1 |
|
interleukin-4 - physiology |
1 |
|
interleukin-6 |
1 |
|
interleukin-8 |
1 |
|
interleukins - biosynthesis - pharmacology |
1 |
|
interleukins - immunology |
1 |
|
interleukins - metabolism |
1 |
|
interstitial lung disease |
1 |
|
intradermal tests |
1 |
|
intravenous immunoglobulin |
1 |
|
inuits - genetics |
1 |
|
isoelectric focusing |
1 |
|
jak inhibitor |
1 |
|
juvenile rheumatoid arthritis |
1 |
|
kappa locus |
1 |
|
leukocyte adhesion deficiency |
1 |
|
linkage (genetics) |
1 |
|
liquid |
1 |
|
live attenuated influenza vaccine |
1 |
|
liver abscess |
1 |
|
lung - pathology - surgery |
1 |
|
lung - radionuclide imaging |
1 |
|
lymphocytes - pathology - ultrastructure |
1 |
|
lymphopenia |
1 |
|
macrophage activation syndrome |
1 |
|
management plan |
1 |
|
mannan-binding lectin |
1 |
|
mannan-binding protein |
1 |
|
mannose - metabolism |
1 |
|
mannose binding protein |
1 |
|
mannose-binding lectin - metabolism |
1 |
|
mannose-binding protein-associated serine proteases - deficiency - genetics |
1 |
|
measles - prevention & control |
1 |
|
measles-epidemiology |
1 |
|
measles-mumps-rubella vaccine |
1 |
|
measles-mumps-rubella vaccine - administration & dosage - immunology |
1 |
|
measles-mumps-rubella vaccine/administration and dosage/adverse effects |
1 |
|
measles-vaccine |
1 |
|
measles/épidemiology/prevention and control |
1 |
|
membrane glycoproteins - genetics |
1 |
|
meningitis - etiology |
1 |
|
meningitis, pneumococcal - etiology |
1 |
|
meningoencephalitis |
1 |
|
meningoencephalitis - microbiology |
1 |
|
microscopy, electron, scanning |
1 |
|
models, genetic |
1 |
|
moyamoya disease - complications - radiography |
1 |
|
msmd |
1 |
|
mucocutaneous lymph node syndrome - ethnology - immunology |
1 |
|
multisystem inflammatory syndrome in children |
1 |
|
mumps - prevention & control |
1 |
|
mutagenesis, site-directed |
1 |
|
mutation, missense - genetics |
1 |
|
mycobacterium bovis |
1 |
|
mycobacterium bovis - immunology |
1 |
|
myelokathexis |
1 |
|
nadph oxidase - genetics |
1 |
|
natural antibody |
1 |
|
neonatal intensive care |
1 |
|
neurological |
1 |
|
newborns |
1 |
|
next generation sequencing |
1 |
|
nitroblue tetrazolium test |
1 |
|
nod-2 |
1 |
|
nomid |
1 |
|
nonprogression |
1 |
|
nontherapeutic human experimentation |
1 |
|
non‐therapeutic research |
1 |
|
nucleic acid hybridization |
1 |
|
opsonin proteins - blood |
1 |
|
opsonisation |
1 |
|
papua new guinea |
1 |
|
parental consent |
1 |
|
parents - psychology |
1 |
|
particulate matter - analysis - toxicity |
1 |
|
patch test |
1 |
|
patient selection |
1 |
|
peanut hypersensitivity - etiology |
1 |
|
pedigree |
1 |
|
peptide nucleic acid |
1 |
|
percentile ranges |
1 |
|
phosphoglycerate kinase - analysis - genetics |
1 |
|
pituitary neoplasms - complications - radiography |
1 |
|
placebos - administration & dosage |
1 |
|
plant oils - adverse effects |
1 |
|
pneumonia - complications |
1 |
|
populations |
1 |
|
porcine circovirus-free |
1 |
|
prednisolone |
1 |
|
primary antibody deficiency |
1 |
|
primary immune deficiencies |
1 |
|
prophylactic antibiotics |
1 |
|
protein subunits - biosynthesis |
1 |
|
protein subunits - blood |
1 |
|
proteins - genetics |
1 |
|
proto-oncogene proteins - metabolism |
1 |
|
pulmonary fibrosis - immunology - radionuclide imaging |
1 |
|
q-flow fish |
1 |
|
questionnaires - standards |
1 |
|
radioallergosorbent test |
1 |
|
reactogenicity |
1 |
|
reagent kits, diagnostic |
1 |
|
renal artery stenosis |
1 |
|
renal stones |
1 |
|
respiration, artificial |
1 |
|
respiratory function |
1 |
|
rhinitis - diagnosis |
1 |
|
rhodamines - diagnostic use |
1 |
|
risk of bacteremia during ventilation |
1 |
|
risks |
1 |
|
rix4414 |
1 |
|
rna splice sites - genetics |
1 |
|
rotavirus infections - prevention & control |
1 |
|
rotavirus vaccines - administration & dosage |
1 |
|
rubella - prevention & control |
1 |
|
san bushmen |
1 |
|
school outreach vaccination program |
1 |
|
seizure |
1 |
|
sensitivity and specificity |
1 |
|
sepsis - microbiology |
1 |
|
severe combined immune deficiency |
1 |
|
sex |
1 |
|
sex chromosome aberrations - enzymology - genetics |
1 |
|
sex chromosome aberrations - genetics |
1 |
|
sex influence |
1 |
|
skin - pathology |
1 |
|
snake bites - pathology - surgery |
1 |
|
social perception |
1 |
|
south africa |
1 |
|
sputum - microbiology |
1 |
|
staphylococcus - isolation & purification |
1 |
|
stat1 deficiency |
1 |
|
stat1 mutation |
1 |
|
stat3 deficiency |
1 |
|
stat3 inhibitor |
1 |
|
streptococcal infections - etiology |
1 |
|
streptococcus agalactiae - isolation & purification |
1 |
|
streptococcus pyogenes |
1 |
|
t regulatory cell |
1 |
|
t-helper cells |
1 |
|
t-lymphocytes - analysis - enzymology |
1 |
|
t-suppressor cells |
1 |
|
takayasu arteritis - complications - immunology |
1 |
|
takayasu's arteritis |
1 |
|
telomere |
1 |
|
telomere length |
1 |
|
tgfb1 |
1 |
|
tnfa |
1 |
|
tnfr1 |
1 |
|
trachea - microbiology |
1 |
|
tracheal cultures |
1 |
|
transcription factor relb |
1 |
|
transcription factors - metabolism |
1 |
|
trend prevalence |
1 |
|
trimethoprim-sulfamethoxazole combination - therapeutic use |
1 |
|
tuberculosis, pulmonary - complications - drug therapy - radiography |
1 |
|
tuberculosis, pulmonary - genetics |
1 |
|
tumor necrosis factor-alpha - biosynthesis |
1 |
|
tumor necrosis factor-alpha - immunology - metabolism |
1 |
|
type i ifn signaling |
1 |
|
urticaria |
1 |
|
usual interstitial pneumonitis |
1 |
|
vaccination - methods |
1 |
|
vaccination- |
1 |
|
vaccine interference |
1 |
|
vaccines, attenuated - administration & dosage |
1 |
|
vaccines, attenuated - administration & dosage - immunology |
1 |
|
vaccines, attenuated - adverse effects - immunology |
1 |
|
vaccines, combined - administration & dosage - immunology |
1 |
|
vanuatu |
1 |
|
varicella vaccination |
1 |
|
varicella zoster virus |
1 |
|
varicella-zoster virus |
1 |
|
venepuncture |
1 |
|
warts |
1 |
|
wes |
1 |
|
wiskott-aldrich syndrome - complications - immunology |
1 |
|
wiskott-aldrich syndrome - diagnosis - genetics |
1 |
|
wiskott-aldrich syndrome - immunology |
1 |
|
wiskott-aldrich syndrome protein |
1 |
|
wiskott‐aldrich syndrome |
1 |
|
x-linked inhibitor of apoptosis |
1 |
|
x-linked lymphoproliferative syndrome |
1 |
|
xhosa |
1 |
|
zambia |
1 |
